Years after infection with hepatitis B virus, chimpanzees may have manifestations of the carrier state as described in man. In addition to serologic evidence for persistent viral infection, percutaneous liver biopsy specimens showed hepatitis B virus surface antigen in the cytoplasm and hepatitis B virus core antigen in the nucleus. Four (3,4). Recently, two distinct types of experimental hepatitis B have been described in chimpanzees, one with rapid resolution and the other with smoldering features characterized by portal inflammatory cell infiltration present for more than 1 year (5). After acute infection, some animals became long-term HBV carriers, maintaining elevated levels of HBsAg, antibody to hepatitis B core antigen (anti-HBc), and Dane particles in the serum. Therefore, it appeared important to study such chimpanzee carriers (a) to establish the histologic features in these chimpanzees, (b) to correlate serologic observations with immunohistochemical findings in the liver, and (c) to characterize the nature of viral DNA in the hepatocytes. This was considered important because human HBV carriers have a significant risk of developing hepatocellular carcinoma (6). In a human hepatocellular carcinoma line (PLC/PRF/5) in tissue culture, HBV DNA has recently been found to be integrated into the host genome (7,8). With development of newer techniques in nucleic acid analysis and availability of recombinant cloned HBV DNA probes (9-14), this question could be addressed in small samples of liver by using very sensitive techniques.We have examined percutaneous liver biopsy specimens and serum from known chimpanzee HBV carriers that were infected experimentally or in the wild. By using a 32P-labeled